Chemotherapy following radium‐223 dichloride treatment in ALSYMPCA

Sartor, Oliver; Hoskin, Peter; E. Coleman, Robert; Nilsson, Sten; J. Vogelzang, Nicholas; Petrenciuc, Oana; Staudacher, Karin; Thuresson, Marcus; Parker, Christopher

doi:10.1002/pros.23180

Public

Chemotherapy following radium‐223 dichloride treatment in ALSYMPCA

Shared by NobleBlocks on Mar 23, 2016 • 12:00 AM UTC

Authors:

Oliver Sartor

Peter Hoskin

Robert E. Coleman

Abstract

BACKGROUND Radium‐223 prolongs overall survival in patients with castration‐resistant prostate cancer (CRPC) and symptomatic bone metastases, regardless of prior docetaxel. Whether or not chemotherapy can be safely administered following radium‐223 treatment is of clinical importance. An exploratory...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!